The Cigna Group (NYSE:CI – Get Free Report) had its price objective lowered by Stephens from $410.00 to $380.00 in a report issued on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the health services provider’s stock. Stephens’ target price indicates a potential upside of 28.94% from the company’s current price.
A number of other equities analysts also recently weighed in on CI. Royal Bank of Canada cut their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Cantor Fitzgerald cut their price target on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Friday. Deutsche Bank Aktiengesellschaft cut their price target on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Piper Sandler reissued an “overweight” rating and issued a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Finally, StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, The Cigna Group currently has a consensus rating of “Buy” and a consensus target price of $383.50.
Check Out Our Latest Stock Analysis on CI
The Cigna Group Trading Up 4.1 %
The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. During the same quarter in the previous year, the company posted $6.79 EPS. As a group, sell-side analysts predict that The Cigna Group will post 28.5 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Collier Financial acquired a new stake in shares of The Cigna Group during the fourth quarter worth approximately $32,000. ORG Wealth Partners LLC acquired a new stake in The Cigna Group in the fourth quarter valued at approximately $34,000. Ulland Investment Advisors LLC lifted its stake in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group in the third quarter worth $37,000. Finally, Compagnie Lombard Odier SCmA acquired a new stake in shares of The Cigna Group in the fourth quarter worth $37,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
- Five stocks we like better than The Cigna Group
- What is the Nikkei 225 index?
- The Best Way to Invest in Gold Is…
- Energy and Oil Stocks Explained
- Why Nike Stock Could Be 2025’s Top Comeback Play
- What is MarketRank™? How to Use it
- Uber Stock Gaining Speed: Analysts See 30% Upside
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.